An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.
基于 IL-15 的超激动剂 ALT-803 可增强 NK 细胞对西妥昔单抗治疗的头颈部鳞状细胞癌的反应
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-019-02372-2
Pinette Ashley, McMichael Elizabeth, Courtney Nicholas B, Duggan Megan, Benner Brooke N, Choueiry Fouad, Yu Lianbo, Abood David, Mace Thomas A, Carson William E 3rd
